Fast Determination of Human Insulin and Its Deamidation Product by Electrospray Ionization Mass Spectrometry by Rojsajjakul, Teerapat
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Masters Theses Graduate School 
8-2007 
Fast Determination of Human Insulin and Its Deamidation Product 
by Electrospray Ionization Mass Spectrometry 
Teerapat Rojsajjakul 
University of Tennessee - Knoxville 
Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes 
 Part of the Chemistry Commons 
Recommended Citation 
Rojsajjakul, Teerapat, "Fast Determination of Human Insulin and Its Deamidation Product by Electrospray 
Ionization Mass Spectrometry. " Master's Thesis, University of Tennessee, 2007. 
https://trace.tennessee.edu/utk_gradthes/202 
This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and 
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE: 
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu. 
To the Graduate Council: 
I am submitting herewith a thesis written by Teerapat Rojsajjakul entitled "Fast Determination of 
Human Insulin and Its Deamidation Product by Electrospray Ionization Mass Spectrometry." I 
have examined the final electronic copy of this thesis for form and content and recommend that 
it be accepted in partial fulfillment of the requirements for the degree of Master of Science, with 
a major in Chemistry. 
Kelsey D. Cook, Major Professor 
We have read this thesis and recommend its acceptance: 
Michael Sepaniak, Charles Feigerle 
Accepted for the Council: 
Carolyn R. Hodges 
Vice Provost and Dean of the Graduate School 




To the Graduate Council: 
 
I am submitting herewith a thesis written by Teerapat Rojsajjakul entitled “Fast 
Determination of Human Insulin and Its Deamidation Product by Electrospray Ionization 
Mass Spectrometry” I have examined the final electronic copy of this thesis for form and 
content and recommend that it be accepted in partial fulfillment of the requirements for 
the degree of Master of Science, with a major in Chemistry. 
      
 
 
                           
          
______________________________ 
        Dr. Kelsey D. Cook, Major Advisor 
      
We have read this thesis 








Dr. Charles Feigerle 
    Accepted for the council: 




                  Carolyn R. Hodges, Vice Provost and  
















 FAST DETERMINATION OF HUMAN INSULIN AND ITS DEAMIDATION 


















Presented for the 
 
Master of Science Degree 
 
















Teerapat   Rojsajjakul 
 
August  2007 
 
     ii 
ACKNOWLEDGEMENTS 
 
I would like to thank Prof. Kelsey D. Cook for his guidance, encouragement, and 
financial support, Prof. Michael Sepaniak and Prof. Charles Feigerle for serving on my 
supervisory committee and Dr. Al Tuinman, for help in the Mass spectrometry center.  I 
would also like to thank to current and past group members, Dr. Maolian Chen, Yu Zhu, 
Eloise Joyce, Elizabeth Stewart, Andrew Dykstra, Yao (Bella) Huifang and Dr. Liguo 
















     iii 
ABSTRACT 
Application of the electrospray ionization (ESI) technique in mass spectrometry 
(MS) has played an important role in analysis of biological molecules and polymers. The 
focus of this thesis is to assess and extend the application of this technique in the rapid 
determination of human insulin and its deamidation product. 
Quantitative assessment of deamidation of human insulin generally invokes 
relatively slow chromatographic analysis.  Faster cost-effective analysis using mass 
spectrometry with a low-resolution analyzer is challenging because the deamidation 
product is only one Dalton heavier than the 5808-Da protein; low-level contamination has 
only a small effect on the isotope envelope.  Exploiting the chemical differences between 
insulin and its deamidation product (6 carboxylic acids, vs 7 following deamidation), we 
have extended an application of an alternative MS method based on the relative 
intensities of the high charge states in negative ion electrospray, using isopropylamine 
(IPA) to enhance anion intensities. Source parameters were optimized for high sensitivity 
and stability of higher charge states. 
The intensities of the higher charge states were increased in proportion to the 
amount of the deamidation product present in the mixtures. From the various ratios of the 
deamidation product, the study shows that this method was able to determine the ratio of 
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TECHNICAL ABSTRACT 
Application of the electrospray ionization (ESI) technique in mass spectrometry 
(MS) has played an important role in analysis of biological molecules and polymers. The 
focus of this thesis is to assess and extend the application of this technique in the rapid 
determination of human insulin and its deamidation product. 
Quantitative assessment of deamidation of human insulin generally invokes 
relatively slow chromatographic analysis.  Faster cost-effective analysis using mass 
spectrometry with a low-resolution analyzer is challenging because the deamidation 
product is only one Dalton heavier than the 5808-Da protein; low-level contamination has 
only a small effect on the isotope envelope.  Exploiting the chemical differences between 
insulin and its deamidation product (6 carboxylic acids, vs 7 following deamidation), we 
have extented an application of an alternative MS method based on the relative intensities 
of the high charge states in negative ion electrospray, using isopropylamine (IPA) to 
enhance anion intensities and source parameters were optimized for high sensitivity and 
stability of higher charge states. 
The results show that the intensities of the higher charge states were increased in 
proportion to the amount of the deamidation product present in the mixtures. From the 
various ratios of the deamidation product, the study shows that this method was able to 
determine the ratio of the deamidation product in one minute with LOD = 0.7 % 
deamidation. 
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CHAPTER 1  
INTRODUCTION: HUMAN INSULIN AND ITS SEPARATIONS 
Insulin is a pancreatic hormone protein secreted by the beta cells of the islets of 
Langerhans. It is essential for the metabolism of carbohydrates and the regulation of 
glucose levels in the blood, an inadequate level of insulin in the blood results in the onset 
of diabetes mellitus [1]. Human insulin is composed of 51 amino acid residues and has a 
molecular weight of 5808 Da.  It consists of two polypeptide chains, A and B, linked 
together by disulfide bonds. Chain A has 21 amino acid residues and an intrachain 
disulfide, which links between position A6 and A11.  The chain B polypeptide has 30 
amino acid residues.  Two interchain disulfide bonds are connected between A7 and B7, 
and between A20 and B19.  The sequence of the insulin is shown in Figure 1.1 [1].   
The comercial production of human insulin is a relatively large scale process 
because the need for medical insulin is several tons a year [2]. Purity of insulin is very 





Figure 1.1  The sequence of human insulin and the deamidation sites. 
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purer the insulin the better it is for clinical efficacy and safety of patients.  It is generally 
known that impurities in insulin are responsible for the immunogenicity of recrystallized 
insulin in patients. Most patients who receive insulin for long periods develop antibodies to 
insulin.  In fact, these antibodies are more related to the impurities of insulin than the active 
sites of insulin.   
The most common side reaction in manufacturing human insulin is deamidation, 
which may occur in both acidic and neutral solution [3].  This is because asparagine 
(Asn) and glutamine (Gln) are acid labile, meaning they can be hydrolyzed in acidic 
solution and become aspartic acid (Asp) and glutamic acid (Glu), respectively. The 
reaction can occur faster at high temperature.  In human insulin, there are three 
asparagine residues at A18, A21 and B3, and three glutamine residues at A5, A15, and 
B4.  Most complication arises when amino acid A21 is hydrolyzed and the amide group 
is changed to carboxylic group. As a consequence, the deamidation product of human 
insulin may affect the receptor binding sites and immunogenicity in the human body.  
Even though insulin prepared by biotechnological or chemical techniques is less 
contaminated than in the past, the deamidation product is an unwanted side product and 




RCONH2                       RCOOH           
Figure 1.2 Deamidation reaction 
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During storage of human insulin in acidic solution, the deamidation product from 
A21 of human insulin is a major product while the deamidation and racemization reaction 
at B3 may dominate in neutral solution [4].  In addition to the deamidation reaction, 
human insulin may undergo covalent cross-linkage forming dimers and higher molecular 
weight transformation products, which decrease the activity of the native insulin.   
 
1.1. Separation of human insulin and its deamidation product 
Chromatography is the common method for separation and detection of the 
deamidation product.  For many years, in this application, reversed phase high 
performance chromatography (RP-HPLC) has been a standard tool in separations because 
of its versatility and wide dynamic range.  For example, Eli Lilly uses a C8 RP-HPLC for 
routine determination of insulin and its deamidation product. However, this method is 
relatively slow, making it less than ideal for the needs of pharmaceutical manufacturing. 
 
1.2 Reversed Phase High Performance Chromatography (RP-HPLC) 
Liquid chromatography has become one of the most important tools in 
separations. It is suitable for most analytes that are not sufficiently volatile for gas 
chromatography. HPLC in particular has been developed and has become a standard tool 
for both quantitative and qualitative analysis. In this system, high pressure is applied to 
deliver solvent (mobile phase) through a close-packed column of fine particles or 
chemically cross-linked substance (stationary phase). The strength of the mobile phase, 
type of the stationary phase, and pressure play important roles in the quality of the 
separations. There are many types of stationary phases for HPLC, which have different 
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separation mechanisms such as ion-exchange, molecular exclusion, affinity and 
adsorption chromatography (including reversed phase chromatography). 
 RP HPLC is a separation technique that uses the hydrophobic interactions 
between the analyte and the stationary phase.  In general, non-polar alkyl chains are 
covalently attached to a silica surface to make fine particles for the packed column. The 
most common non-polar stationary phases are shown below. 
R = (CH2)3CH3   Butyl group (C4) 
R = (CH2)7CH3   Octyl group (C8) 
R = (CH2)17CH3   Octadecyl group (C18) 
R = C6H5    Phenyl group               (where R is an alkyl chain). 
 This interaction mechanism can provide high resolution for separation.  In fact, 
RP-HPLC is able to separate proteins of nearly identical sequences, such as insulin 
variants, which differ by a single amino acid.  For proteins, the separation relies on the 
interaction between the amino acid side chains and the stationary phase. Under typical 
optimized conditions, the separation time for human insulin and its deamidation product 
by C8 RP-HPLC is about 20 minutes, which is relatively slow. 
 
Improvement of RP-HPLC, has been reported by using an isotherm approach [4].  
In this study, human insulin and its deamidation product were separated by pulsed mobile 
phase experiment using ODS-AM C18 stationary phase with a particle diameter of 5 
microns.  An ethanol-water mixture (29.8%: 70.2% (w/w)) was used as the mobile phase,  
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Figure 1.3 Separation of human insulin and its deamidation product in a pulsed 
experiment with C18 RP-HPLC [4]. 
 
buffered with 50 mM ammonium sulfate at pH 3.5.  In this case, human insulin and its 
deamidation product were eluted at 10.2 and 13.0 min, respectively.  The chromatogram 
of this separation is shown in Figure 1.3. 
 
1.3 Reversed Phase Ultra High Performance Chromatography (RP-UPLC) 
With the same mechanism as RP-HPLC, reversed phase ultra-high performance 
chromatography (RP-UPLC) operates under ultra-high pressure to perform the 
chromatographic separation [5, 6]. This system has advantages for speed and capability 
of operation at a maximum pressure up to 15000 psi (1000 bar).  Separations at ultra-high 
pressure can obtain efficiencies of greater than 200000 theoretical plates/meter.  
However, RP-UPLC is relatively new. Thus the stationary phases for this type of 
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separation are in development. Many factors need to be considered for short column 
packing with small particles such as: 
Small volume device (for low band spreading) 
Fast, efficient detector (for example, a mass spectrometer and a fluorometer) 
Advanced stationary phase and packing techniques 
Hardware and software 
 
For separation of human insulin and its deamidation product, RP-UPLC is a new 
candidate for an alternative method when speed is required. However, reproducibility is 
another issue that needs to be improved.  The separation time for human insulin and its 
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CHAPTER 2  
ELECTROSPRAY MASS SPECTROMETRY AND GAS PHASE CHEMISTRY 
 
2.1. Electrospray Ionization Mass Spectrometry  
Electrospray ionization (ESI) is a method by which the analytes present in 
solution can be ionized and transferred to mass analyzers. This indispensable method is a 
“soft ionization” technique because it allows detection of intact molecular ions of large, 
nonvolatile species. These are generated from a solution in a small capillary by applying 
a potential difference of 3-6 kV between the capillary and a counter electrode under 
atmospheric pressure.  The concentration of the analyte (generally low in a volatile 
solvent) can be micromolar or lower depending on types of mass analyzers, analytes and 
the detectors.  The experiment and the characteristics of ESI were pioneered by Dole in 















10-4 – 10-5 mbar 
Figure 2.1 Standard electrospray ionization source 
Later, electrospray ionization was developed for the analysis of macromolecules, 
including biolomolecules and polymers, by Fenn, who was awarded for the Nobel Prize 
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in Chemistry in 2002 [8].   
In general, the formation of ions in ESI involves three main steps: first, the 
formation of charged droplets, second, the evaporation of solvent, resulting in shrinkage 
of the droplet and third, formation of smaller charged droplets and ions in gas phase.  As 
the analyte (usually in a volatile polar solvent) is pumped through narrow capillary, 
(usually made of stainless steel), a high voltage (3-6 kV) is applied to the tip of the 
capillary, producing a spray of highly charged droplets. As the solvent evaporates, the 
droplets became smaller, finally disintegrated into many small charged droplets without 
the solvent. These small charge droplets move through the orifice by the difference of 
voltage and pressure.  















Droplet containing ions 
Capillary, 3 – 6 kV 
Evapolating of solvent 
Figure 2.2 The electrospray ionization process. 
with multiple charge states, which depend upon the characteristics of the structure, 
conformation and functional groups of the analytes.  
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2.2. Gas Phase Chemistry in ESI 
Dole et al. [7] studied negative macroions of a dilute polymer solution, which was 
produced by sampling the gaseous mixture of macroions, solvent, and nitrogen molecules 
with a nozzle-skimmer system. The results showed that polystyrene macroions with 
average molecular weight of 51 000 Da tend to form dimers and trimers in the beam, and 
the larger polystyrene macroions, which have an average molecular weight of 411 000 
Da, are most likely to form multiply charged single species. This is because during the 
transit of the macroions in the supersonic beam, the ions become more concentrated due 
to the higher volatility of solvent.  However, the reason why decreasing mass-to-charge 
ratios of high molecular mass solutes yield higher charged ions was not clear at that time 
[8].  To explain this problem, John B. Fenn, suggested that the charge state distributions 
of noncovalent macromolecule clusters, either of proteins or polymers, are related to their 
droplet charge densities [9]. These charge densities result from the rate of desorption in 
the ionization process, such that the number of charge states depends on the number of 
charges on the droplet surface.  This generally explains why higher mass-to-charge ratios 
have fewer charge states or the other way around.   
 
In practice, the number of charge states in biomolecular ESI depends upon the 
number of acidic sites in proteins or peptides in positive ion ESI [10], and the number of 
basic sites in negative ion ESI, and relates to protonation and deprotonation of those sites 
in ESI.  In this regard, the protonation of amino acids lysine, arginine and histidine yield 
positive ions.  In negative ESI, the deprotonation of aspartic acid and glutamic acid yield 
negative ions.  In some proteins, the maximum number of charges is decreased because 
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of disulfide bonds [11]; in the compact conformation of proteins induced by disulfide 
linkages, both basic and acidic sites can be protected. This will shift the charge states to 
lower number in ESI.   
Environmental factors also play an important role in the charge state distribution. 
The distribution can be manipulated depending on many factors such as pH, solvent, 
concentration, additives, structures, conformations and instrument conditions. The most 
sensitive variable affecting the charge state distribution is the pH of the solution.  
A convenient method for manipulating charge state distribution was demonstrated 
by Leenheer [12], who developed a method for quantitative analysis for analysis of 
proteins. In this study, human insulin was used for the model of charge distribution under 
conditions of varying pH in solution and varying instrumental conditions. The study 
showed that gas phase formic acid, introduced via a bubble trap in the nebulizing gas line 
promoted the highest positive charge state of human insulin in postive ion ESI. 
Conversely, gas phase isopropylamine enhanced the highest charge state of human 
insulin in negative ion ESI.  In addition, the instrumental parameters, such as cone 
voltage, capillary temperature and the flow rate of the nebulizing gas were optimized for 
the best distribution of the charge states. The results from this study are shown in Figure 
2.3 [12].  
The experiment carried out and reported in Figure 3D, is “wrong-way-round” ESI 
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Figure 2.3 Positive and negative ion electrospray ionization mass spectra of human 
insulin; in positive ESI: with neutral solution (A), with 1% formic acid solution (B), with 
gas phase formic acid (C), with 0.003% formic acid and gas phase isopropylamine (D); in 
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[13], in which the positive ion ESI was operated under basic conditions. Under these 
conditions, the lower positive charge states were expected to be favorable.  Generally, in 
negative ion ESI, gas phase isopropylamine gives better sensitivity, compared to the 
solution phase and the charge states shift towards the higher charge states.  
 
2.3. Electrical Discharge (Corona Discharge) 
  Corona discharge is a charge reduction process in ESI, resulting in a change in 
appearance of the mass spectrum [13, 14]. It usually takes place between the capillary 
and counter electrode. This phenomenon can reduce the charge states induce 
fragmentation and/or prevent observation of many ions in ESI. Corona discharge can take 
place very readily under a negative potential at the spray tip of capillary. This is because 
the field emission of electrons from the tip does not require a very high voltage. In this 
process, both positive and negative charge carriers are formed and recombine with 
droplets having the opposite charge [15]. As a result, droplet charges are neutralized and 
the ions for most analytes no longer appear in mass spectra.  Even though these ions are 
sensitive to corona discharge and usually disappear in mass spectra, this problem can 
minimized by adjusting parameters of the mass spectrometer such as lowering the electric 
field. 
A low-resolution mass spectrometer does not provide enough resolution to 
distinguish human insulin and its deamidation product by regular ESI.  This is because 
deamidation induces only a 1 Da change in mass (CONH2 → COOH) out of a total mass 
of 5808. Thus, direct MS determination is difficult at low resolution due to interference 
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between the deamidation product and the 13C isotopic peaks of the native protein. 
Our goal is to extend the gas phase isopropylamine method [12] to determine the 
ratio of human insulin and its deamidation products in negative ion ESI for high speed 
and throughput. This is because the current method, RP HPLC, which has been used for 
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HPLC-grade acetonitrile (MeCN) and water were purchased from Fisher Scientific 
(Pittsburgh, PA). Reagent-grade formic acid (95% in water) and trifluoroacetic acid 
(TFA) were purchased from Pierce Biotechnology Inc. (Rockford, IL).   Formic acid 
(FA) and human insulin were purchased from Sigma Chemicals (St. Louis, MO). 
Isopropylamine was purchased from Eastman Organic Chemical (Rochester, NY). All 
reagents were used without further purification. 
 
3.2. Preparation of the Deamidation Samples:   
There are two sets of samples were used in this study. All were prepared from stock 
solutions of human insulin (3 mg/mL in 0.1 aqueous formic acid). In Set 1, a stock 
solution was aged for 2 months at room temperature to promote deamidation. Aliquots of 
this solution were mixed with aliquots a fresh solution to prepare 3 samples (1 mL) of 
varying deamidation concentrations, labeled sample 1, 2 and 3.  In Set 2, a stock solution 
of human insulin was aged for 4 months at 4 °C to promote deamidation. Aliquots of this 
solution were mixed with aliquots a fresh solution to prepare 5 samples of varying 
deamidation concentrations, labeled sample 4, 5, 6, 7 and 8. 
 
3.3. Determination of Human Insulin and Its Deamidation Product by HPLC:   
The various mixtures of human insulin and its deamidation product from set 1 and set 2 
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were analyzed by reversed phase HPLC using a Hewlett-Packard (Palo Alto, CA) 1100 
system with a C8 reversed phase column (4.6 mm x 150) at 25 °C. Solvent A was 0.05% 
TFA in water, and solvent B was 0.05% TFA in MeCN. The flow rate through the 
column was 1.0 mL/min.  Each 20 μL (approximately 10 nanoMolar) sample was 
injected, using a Rheodyne 8125 injector (Alltech, Deerfield, IL). The column was 
equilibrated at 10% solvent B prior to injection. For set 1, the sample was eluted with a 
linear gradient from 10 to 30% solvent B over a 45 min-period; for Set 2, the linear 
gradient was from 10 to 20% solvent B over 45 min. The longer gradient in Set 2 was for 
a better separation. The separation was monitored by absorbance 280 nm. ChemStation 
software (Hewlett Packard, Palo Alto, CA) was used to determine peak areas. 
 
3.4. Determination of Human Insulin and Its Deamidation Product by Mass 
Spectrometry:  
A Micromass (Manchester, UK) Quattro II triple quadrupole mass spectrometer 
was used to acquire ESI mass spectra. An HPLC in-line bubble trap (Alltech, IL, US; part 
no. 01-0221, 1/16”) was inserted in the nebulizing gas line in a “head-down’ manner 
[12].  
The chamber of the bubble trap is screw-capped with a 200 μL plastic vial filled 
with isopropylamine inside (Figure 3.1).  Source parameters were optimized for high 
sensitivity and stability for the highest charge states in the negative ion mode. The source 
temperature was 120 °C.  Flow rates of nitrogen nebulizing and drying gas were 20 and 
200 L/h, respectively. The capillary voltage was 2.50 kV, and the cone voltage was 30 V.   








Figure 3.1 The bubble trap in the standard nebulizing gas line of the Quattro II mass 
spectrometer. 
 
About 2 μL of each mixture were diluted with 1mL 50% ACN: H2O.  Each sample was 
infused to the ESI source by a Harvard Apparatus (South Natick, MA) syringe pump at a 
flow rate of 5 μL/min. Mass spectra were acquired in the accumulation mode from 700 to 
1300 m/z for 1 min (17 scans) for Set 1 and 700 to 1500 m/z for 1 min (17 scans) for Set 
2. Ten replicates for set 1 and five replicate for set 2 were used for each sample. The 
change in the range of the scan in Set 2 was to obtain more number of charge states.  
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CHAPTER 4  
RESULTS AND DISCUSSION 
 
4.1. Results from C8 reversed phase HPLC 
The three mixtures from Set 1 were determined by C8 reversed phase HPLC to be 
approximately 1%, 30% and 60% hydrolyzed, respectively. The results suggest that the 
deamidation may simply occur either in the acidic condition or in solution at above 37°C 
[3].  We were interested in even smaller ratios of the demidation product in the range of 
the problematic for pharmaceutical manufacturing. Therefore, experiment set 2 was 
carried out at 4°C for 4 months. The results from C8 reversed phase HPLC for five 
samples were 0.9%, 5.4%, 8.6%, 11.2% and 17.1% deamidation, respectively.  
 
It is interesting to note that the elution time of human insulin and its deamidation 
product does not follow the expected order based on the theory of C8 RP-HPLC.  In 
general, the separation mechanism of reversed phase HPLC depends on hydrophobic 
interactions between the analyte and stationary phase.  The amide group of human insulin 
should be more hydrophobic than the carboxyl group in the deamidation product.  
Therefore, human insulin should have a stronger interaction and elute after the 
deamidation product.  On the contrary, in this separation, the deamidation product elutes 
after the human insulin.  The results suggest that deamidation changes the conformation 
of human insulin and makes it more hydrophobic, resulting in longer retention by the C8 
reversed phase, which agrees with reference [4]. An example of C8 RP-HPLC is shown 
in Figure 4.1. 

























Figure 4.1 Chromatogram of sample 1 of human insulin and its deamidation product by 
C8 RP-HPLC, which has 11.2 % of the deamidation product. 
 
The samples from both set 1 and 2 were analyzed by the mass spectrometric 
method to improve the determination speed of the deamidation product in human insulin 
samples.  
 
4.2. Results from Gas Phase Isopropylamine in Negative ESI Mass Spectrometry. 
Adjusting the Quattro II triple quadrupole mass spectrometer’s parameters. The 
instrument’s parameters were adjusted for high sensitivity and stability of the higher 
charge states.  The source temperature was 120 °C.  Adjusting the source temperature 
higher and lower than 120 °C affected the intensity of the highest charge states, which 
could be –7 and –8.  The most sensitive parameters were the cone voltage and the flow 
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rates of nebulizing and drying gas.  Increasing the cone voltage from 25 V shifted the 
spectra of human insulin to lower charge states [12].  On the other hand, lowering the 
voltage from 25 V increased the intensity of the higher charge states but it also affected 
the stability of the higher charge states.  The flow rates of the nebulizing and drying gas 
were also important for the stability of the higher charge states. The flow rates of 
nebulizing and drying gas in this experiment were chosen at 20 and 200 L/h, respectively. 
The flow rates of the nebulizing gas and the drying gas should be optimized because 
isopropylamine was introduced in the nebulizing gas line. If the flow rate of the drying 
gas was high, the stability and the intensity of the charge states were decreased due to the 
decrease of the concentration of isopropylamine in the gas phase and the flow fluctuation. 
 
ESI mass spectra of human insulin.  A feature of ESI-MS of human insulin is the 
multiply charged ions. The possible charge states in a negative ion ESI mass spectrum 
depend upon the number of carboxylic acid groups in the molecule. Since, human insulin 
has six carboxylic acid groups, the maximum charge state should be – 6. The mass/charge 
ratio (m/z) of each charge state can be calculated by equation below: 
m/z  =  (MW – nH)/n 
Where MW, n and H are the molecular mass, the number of the charge state, and 
hydrogen on the carboxylic acid group, respectively. All possible charge states of human 
insulin are shown in Table 4.1. 
 The Quattro II triple quadrupole mass spectrometer is a low-resolution mass 
spectrometer, which has resolution capability of about 1,000. It is not able to differentiate 
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Table 4.1 All possible charge states of human insulin and * of the deamidation product in 
negative ion ESI. 
Charge State Calculation Mass to charge ratio (m/z) 
-1 m/z = (5808 –1)/1 5807 
-2 m/z = (5808 –2)/2 2903 
-3 m/z = (5808 –3)/3 1935 
-4 m/z = (5808 –4)/4 1451 
-5 m/z = (5808 –5)/5 1160.6 
-6 m/z = (5808 –6)/6 968 
-7* m/z = (5809 –7)/7* 828.8* 
-8* m/z = (5810 –8)/8* 725.2* 
 
 
isotopic clusters of higher charge states of high molecular mass proteins. In human 
insulin, for example, the close-ups of the –6 charge state of the samples of Set 2 are 
shown in Figure 4.2.  
 
Mass spectra of human insulin with and without isopropylamine gas.  Under the same 
parameter of mass spectrometric conditions, a negative ion ESI mass spectrum of 0.9% 
deamidation product in human insulin (~4 μM in 50% acetonitrile:water), without 
isopropylamine gas is shown in Figure 4.3.  
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Figure 4.3 Negative ion ESI mass spectrum of 0.9% deamidation of human insulin (~4 
M in 50% acetonitrile:water), without gas phase isopropylamine 
 
 
Without isopropylamine gas, the maximum charge state in negative ion ESI of 
0.9% deamidation product in human insulin is –6 (m/z = 966.8). However, the relative 
intensity of this charge state is only about 13%.  A negative ion ESI mass spectrum of 
60% deamidation product in human insulin (~4 μM in 50% acetonitrile:water), without 
isopropylamine gas is shown in Figure 4.4. 
The results show that without gas phase isopropylamine the ESI spectra of 0.9% 
deamindation and 60% deamidation of human insulin are slightly different. Even though 
the relative intensity of the –6 charge state of 60% deamidation is about 5% higher than 
the 0.9% deamidation, the determination of human insulin and its deamidation product 
will not be successful at percent of the deamidation mixture. Moreover, the stability of 
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Figure 4.4 Negative ion ESI spectrum of 60% deamidation of human insulin (~4 M in 
50% acetonitrile:water), without gas phase isopropylamine 
 
 
the higher charge state may also affect the measurement.  The ESI mass spectrum of the 
0.9% human insulin at ~ 2 μM in 50% acetonitrile:water under the same concentration 
and mass spectrometric conditions without isopropylamine is shown in Figure 4.5. 
 The negative ion ESI mass spectrum of 0.9% deamidation of human insulin in 
50% acetonitrile:water shows that the signal-to-noise ratio of the –5 charge state of 
human insulin is less than 1. Fortunately, the negative ion ESI mass spectrum shows 
better signals with gas phase isopropylamine under the same mass spectrometric 
conditions.  The ESI mass spectrum of 0.9% deamidation of human insulin at ~ 2 μM in 
50% acetonitrile:water is shown in Figure 4.6. 
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Figure 4.5 Negative ion ESI mass spectrum of 0.9% deamidation of human insulin at ~ 2 







Figure 4.6 Negative ion ESI mass spectrum of 0.9% deamidation of human insulin at ~ 2 
M in 50% acetonitrile:water with gas phase isopropylamine 
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The concentration of insulin in Figure 4.6 is half that in Figure 4.3 but it has 
higher signal-to-noise ratio, suggesting that the isopropylamine gas not only promotes the 
higher charge states but also enhance the signals of insulin in negative ion ESI. 
 
The study of the deamidation product Set 1.  Experimental numerical data of Set 1 are 
shown in Appendix 1. The ESI mass spectra of the deamidation in Set 1 are shown in 
Figure 4.7. 
The sample of Figure 4.7a contained approximately 1% of the deamidation 
product determined by C8 RP HPLC. The average intensity of the charge states are 0%, 
12%, 72%, and 100% for charge states, -8, -7, -6, and -5, respectively. The relative 
intensity the charge state –7 was expected to be close to 0% because this peak should 
derive mainly from the deamidation product, which has more carboxylic acid groups 
compared to human insulin. In this case, the charge state intensity may come from either 
the amount of deamidation product or the response of the mass analyzer.  At 30% of the 
deamidation product (Figure 4.7b), the average intensity for charge states –8, -7, -6 and –
5 are 18%, 68%, 100%, 56% respectively. The shift of the charge states toward the higher 
charge states is consistent with RP-HPLC evidence indicating that the amount of the 
deamidation was increased during the hydrolysis in formic acid solution.  This is related 
to the increasing the amount of carboxylic acid groups, especially at A21 and B3. In 
Figure 4.7c, at approximately 60% of the deamidation product, the average intensity of 
for charge states –8, -7, - 6 and –5 are 35%, 100%, 99% and 37%, respectively. The 
significant relative intensity of the charge state –8, suggests that there are at least two 





















Figure 4.7 ESI Mass Spectra of human insulin samples set 1, including 1%, 30% and 
60% deamidation product in 4.7a, 4.7b and 4.7c, respectively 
 
 
     27 
 sites of the deamidation; pure human insulin should not add to the relative intensity of 
the–7 or –8 charge states because it has only six carboxyl groups. To explain these 
results, the possible sites of the deamidation need to be considered.  In human insulin, 
most deamidation reaction occurs at amino acid positions A21 and B3 [3].  As mentioned 
before, the deamidation of asparagines at A21 is favorable in acidic conditions while the 
reaction at B3 dominates in neutral conditions.  However, both positions can be 
hydrolyzed to some extent under acidic or neutral conditions. Double reaction results in 
two additional carboxylic acid groups, can account for the –8 charge state of in  the mass 
spectra. Moreover, other labile amino acids can also affect the intensity of those charge 
states. Average intensities of the charge states of human insulin and percent of the 
deamidation product for Set 1 are shown in Table 4.2. 
 
The study of the deamidation product in Set 2:  In set 2, samples with five different levels 
of deamidation (0.9%, 5.4%, 8.6%, 11.2% and 17.1% confirmed by RP-HPLC) were 
studied. The instrument parameters were generally the same as in Set 1 but the mass 
range was expanded to m/z 700 – 1500, thus the mass spectra of set 2 include the -4 
 
Table 4.2 Average intensities of the charge states of human insulin and percent of the 






charge state -8 
% Relative 
intensity of 
charge state -7 
% Relative 
intensity of 




1.0 0 + 0 12 + 1 72 + 4 100 + 0 
30.0 18 + 2 68 + 2 100 + 0 56 + 2 
60.0 35 + 2 100 + 1 99 + 2 37 + 1 
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charge state.  The relative intensity of each charge state from these two mass ranges is the 
same because it is only 200 Da different. However, more data points could be considered 
for the determination of human insulin and its deamidation product. Experimental 
numerical data for set 2 are shown in Appendix 2.  The ESI mass spectra of the 
deamidation in set 2 are shown in Figure 4.8. 
The average distribution of charge states intensities of human insulin and percent 
of the deamidation product are shown in table 4.3.  Both set 1 and set 2 show that 
increasing the deamidation product also increases the intensity of charge state –7 and –8. 
 
 
Table 4.3 Average intensity of charge states of human insulin and percent of the 
























0.9 0 + 0 11.8 + 6 51.8 + 2 100 + 0 34.5 + 2 
5.4 0 + 0 19.2 + 2 72.1 + 4 100 + 0 22.6 + 3 
8.6 4.9 + 1 29.2 + 3 86.2 + 4 100 + 0 25.0 + 3 
11.2 8.0 + 1 38.8 + 4 100 + 7 84.2 + 14 12.6 + 2 
17.1 15.6 + 2 49.0 + 7 100 + 0 56.4 + 9 6.9 + 1 
 


























Figure 4.8 Mass spectra of human insulin samples of set 2, including 0.9%, 5.4% and 8.6, 
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4.3. Determination of the Ratio of Human Insulin and Its Deamidation Product by 
ESI Mass Spectrometry 
 
The results from Set 1 and Set 2 show as the amount of deamidation product 
increases, the charge states distributions shift toward the higher charge states. There are many 
ways to construct calibration curves because there are four different charge states in data set 1 
and five charge states in data set 2.  Accuracy, precision, linearity and limit of detection 
(LOD), coefficient of variation (<CV>), and  root mean square error (RMSE) depend upon 
which charge states are used [16, 17]. In this study, three times the standard deviation was 
used to calculate the ratio of the deamidation in the mixture. The quantitative analysis of data 
in Set 1 is shown in Appendix 1 and summarized in Table 4.4.  
 
Table 4.4 Summary of quantitation performances of human insulin in Set 1 
Numerator Denominator LOD <CV> RMSE R2 Plot 
Slope 
7+8 5 0.5 0.51 26.5 0.9874 6.07 
7+8 6 1.2 0.65 15.3 0.9939 2.06 
7+8 5+6 0.9 0.12 5.7 0.9997 1.59 
7+8 5+6+7+8 1.7 0.16 4.6 0.9674 0.73 
7 5 0.7 0.17 19.7 0.9944 4.35 
7 6 1.7 0.47 8.8 0.9831 1.41 
7 5+6 1.2 0.42 4.9 0.9954 1.12 
7 5+6+7+8 2.3 0.30 2.02 0.9343 0.50 
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Deamidation of Human Insulin
































LOD = 0.9% demidation 
Figure 4.9 A plot between the intensities charge state (-8) + (-7) over (-5) +(-6) vs % 
deamidation product. 
 
A plot of the % relative intensity of charges states. (–8) + (–7) over charge state (-
5) + (–6) vs % deamidation product yielded the best straight line with the best R2, small 
<CV> and RMSE and LOD = 0.9% deamidation product, Figure 4.9. 
A plot of the ratio of intensities for charge state –7 to the sum of those for –5 and 
–6 vesus % the deamidation product (from HPLC) also shows good linearity and 
precision in Figure 4.10.  Set 2 was chosen with a lower range of the deamidation product 
concentration and more data points.  There are more possibilities to derive the calibration 
curves because small deamidation product samples were monitored in this set of the mass 
spectra. The calibration curves for this set are shown in Appendix 2 and summarized in 
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Deamidation of Human Insulin

































LOD = 1.2% deamidaion 




Table 4.5 Summary of quantitation performances of human insulin in Set 2 
Numerator Denominator LOD CV RMSE R2 Plot 
Slope 
7+8 5 0.7 3.56 38.0 0.9904 - 
7+8 6 1.4 2.30 21.1 0.9699 2.30 
7+8 5+6 0.6 2.17 10.2 0.9691 1.87 
7+8 4+5+6 0.6 2.26 10.0 0.9651 1.86 
7+8 5+6+7 0.7 1.70 6.6 0.9781 1.34 
7+8 5+6+7+8 1.2 3.90 14.9 0.9793 1.27 
7 5 0.8 4.0 37.1 0.9941 4.75 
7 6 1.9 2.52 20.7 0.9816 1.69 
7 5+6 0.8 2.57 10.7 0.9673 1.49 
7 5+7 0.7 2.25 13.7 0.9687 2.29 
7 5+6+7 0.9 2.02 6.9 0.9811 1.05 
7 5+6+7+8 0.9 2.06 6.9 0.9834 0.99 
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LOD = 0.6% deamidation 
Figure 4.11 A plot between the intensities charge state (-8) + (-7) over (-5) +(-6) vs % 
 
For example, a plot between the percent relative intensity of charges states (–8) + 
(–7) over charge state (-5) + (–6) and % deamidation product yield a straight line with 
LOD = 0.6% deamidation product but high value of the standard deviation, Figure 4.11.  
 
In another example from set 2 (Figure 4.12), the calibration curve was % Intensity 
((-7)+(-8)) / ((-7)+(-6)+(-5)) vs  % deamidation product, yield the best fit with LOD = 
0.7% deamidation. The stability of the charge states in set 1 is better than those in set 2. 
This is because the source capillary diameter (i.d.) in set 1 (0.05 mm) is smaller than in 
set 2 (0.12 mm). Therefore, the efficiency and the uniformity of the spray in set 1 were 
better. If the diameter of the capillaries were the same the result of set 2 would be better. 
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Deamidation of Human Insulin































LOD = 0.7% deamidation 
Figure 4.12 A plot between the intensities charge state (-8) + (-7) over (-5) +(-6) + (-7) vs 
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CHAPTER 5  
CONCLUSIONS 
 
5.1. Application of Gas Phase Isopropylamine in ESI to Determine Ratio of Human 
Insulin and Its Deamidation Product 
 Gas phase isopropylamine with negative ESI enable to differentiate the charge 
states belonging to human insulin and it deamidation product. This is because the 
deamidation product has more of carboxylic acid groups. The intensities of the charge 
states, expecially –7 and –8 charge states can be used to determine the ratio of human 
insulin and its deamidation product.  Accuracy, precision, limit of detection (LOD), and 
linearity depend on which charge states are considered.  The best fit, which plots of the 
relative intensity of ((-8) + (-7)) / ((-7) + (-6) + (-5)) vs % deamidation product yields a 
straight line, LOD = 0.7% deamidation.  
 
5.2. Future Work 
This method will be applied to real samples in pharmaceutical company to 
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Appendix 1 
 
Table A1   Experimental numerical data for Set 1 
Ratio of the deamidation charge -8 charge -7 charge -6 charge -5 
1 0 930752 5805312 9098240 
1 0 824064 4995072 7076608 
1 0 988544 5990912 8007936 
1 0 1080000 6347776 9115648 
1 0 905600 5306880 7076608 
1 0 1017792 5736192 7952384 
1 0 1125760 6310144 8177152 
1 0 1114688 6185472 8326912 
1 0 1038016 5719296 8483840 
1 0 1101632 6035200 8403968 
30 4749568 17240064 26531840 14751744 
30 2518272 10402816 15898624 9013248 
30 2366976 10676224 16206848 8277760 
30 2866944 11963392 17587200 10141696 
30 3955456 15437824 22484992 12223488 
30 3599104 13217792 19234816 10650624 
30 4386048 16625664 24150016 14016512 
30 4819200 17550336 25367552 14633984 
30 4989184 18200576 26153984 14010368 
30 3572736 13234176 18827264 10650624 
60 22152192 63979520 65105920 23493632 
60 23121920 64372736 63168512 23818240 
60 23793664 64913408 65302528 24071168 
60 24822784 65048576 65781760 24043520 
60 24609792 66609152 66859008 24707072 
60 26503168 67637248 65544192 25116672 
60 26735616 67203072 66387968 24603648 
60 26098688 68739072 66080768 25121792 
60 25591808 66174976 65802240 25078784 
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Calibration Curves for % deamidation of human insulin of Set 1.  
1. % Intensity ((-8)+(-7))/((-5)+(-6)) 
Deamidation of Human Insulin

































LOD = 0.9% deamidation product 
 
2. % Intensity (-7)/((-5)+(-6)) 
Deamidation of Human Insulin

































LOD = 1.2% deamidation product 
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3. % Intensity ((-8)+(-7))/((-8)+(-7)+(-6)+(-5)) 
Deamidation of Human Insulin

































LOD = 1.7% demidation  
 
4.  % Intensity (-7)/((-8)+(-7)+(-6)+(-5)) 
Deamidation of Human Insulin































LOD = 2.3% deamidation 
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5. % Intensity ((-7)+(-8))/(-5) 
Deamidation of Human Insulin


























LOD = 0.5% deamidation 
 
6. % Intensity of ((-7)+(-8))/(-6) 
Deamidation of Human Insulin



























LOD = 1.2% deamidation 
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7. % Intensity of (-7)/(-5) 
Deamidation of Human Insulin





















LOD = 0.7% deamidation 
 
8. % Intensity of (-7)/(-6) 
Deamidation of Human Insulin






















LOD = 1.7 % demidation 
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Appendix 2 
 
Table A2   Experimental numerical data for Set 2 
% deamidation  Relative   Intensity of  Charge states 
 -8 -7 -6 -5 -4 
0.9  278656 1223040 2413312 791808 
0.9  303968 1317824 2465280 829568 
0.9  308944 1289475 2595328 833024 
0.9  257744 1128384 2124032 783616 
0.9  233024 1114240 2144512 793536 
      
5.4  1308800 4540352 6054144 1096768 
5.4  1177024 4873984 6344960 1360960 
5.4  1001984 4542976 6505728 1670016 
5.4  1193920 4394752 6098688 1468544 
5.4  1343232 4281088 6403328 1510656 
      
8.6 117752 790656 2836224 3291392 765760 
8.6 219712 953152 2709504 3298048 707520 
8.6 164272 1079872 3080960 3743744 1010944 
8.6 200112 1147136 3636736 4123940 1051904 
8.6 217520 1356736 3795712 4112640 1148160 
      
11.2 248080 1548416 4418048 3303424 541248 
11.2 394960 1855296 5588992 4662784 899904 
11.2 206688 1353280 3048960 3637760 435920 
11.2 142290 931648 2144768 1418816 210496 
11.2 373168 1760960 4660736 4499968 502624 
      
17.1 72116 316992 794304 405056 55732 
17.1 79720 350192 747776 446160 49880 
17.1 65536 353712 712960 426704 57776 
17.1 71088 513296 1065344 460928 76504 
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Calibration Curves for % deamidation of human insulin of Set 2. 
1. % Intensity ((-8)+(-7))/((-8)+(-7)+(-6)+(-5) 
Deamidation of Human Insulin

































LOD = 1.2% deamidation 
 
2. % Intensity (-7)/((-8)+(-7)+(-6)+(-5)) 
Deamidation of Human Insulin




























LOD = 0.9% deamidation 
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3. % Intensity (-7)/((-7)+(-6)+(-5)) 
Deamidation of Human Insulin


























LOD = 0.9% deamidation 
 
4. % Intensity ((-7)+(-8)) / ((-7)+(-6)+(-5)) 
Deamidation of Human Insulin































LOD = 0.7% deamidation 
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5.  % Intensity of ((-7)+(-8))/((-6)+(-5)) 
Deamidation of Human Insulin






























LOD = 0.6% deamidation 
 
6. % Intensity (-7)/((-6)+(-5)) 
Deamidation of Human Insulin


























LOD = 0.8% deamidation 
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7.  % Intensity ((-8)+(-7))/(-6) 
Deamidation of Human Insulin

























LOD = 1.4% deamidation 
 
8. % Intensity (-7)/(-6) 
Deamidation of Human Insulin





















LOD = 1.9% deamidation 
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9. % Intensity (-7)/((-7)+(-5)) 
Deamidation of Human Insulin























LOD = 0.7% deamidation 
 
10. % Intensity ((-7)+(-8)) / (-5) 

























LOD = 0.7% deamidation 
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11. % Intensity of ((-7)+(-8))/((-6)+(-5)+(-4)) 
Deamidation of Human Insulin

































LOD = 0.6% deamidation 
 
12. % Intensity (-7)/(-5) 


























LOD = 0.8 % deamidation  
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